Merck Animal Health Prestige® West Nile Vaccine
- WNV is considered a core vaccination recommended by the AAEP vaccine guidelines and is indicated in the immunization program for all horses each year
- Advanced filtration process through the Antigen Purification System (APS™)
- Exceptional safety profile with the exclusive Havlogen® Adjuvant
INDICATIONS
This product has been shown to be effective for the vaccination of healthy horses 6 months of age or older against West Nile Virus. Duration of immunity has not been established. For more information regarding safety and efficacy data, go to productdata.aphis.usda.gov. This product has been shown to be effective against encephalitis and viremia caused by West Nile Virus.
ADMINISTRATION
Dose
For primary vaccination aseptically administer 1 mL intramuscularly, repeat with a single dose in 3 – 4 weeks. Historically, annual revaccination with this product has been recommended. The need for this booster has not been established. The presence of maternal antibody is known to interfere with the development of active immunity in foals and additional boosters will be required in most young animals. For more information on revaccination frequency, consult your veterinarian.
Caution
Store at 2°-8°C (35°-46°F). Shake well before using. Use entire contents when first opened. Do not mix with other products. This product has not been tested in pregnant animals. Do not vaccinate within 21 days before slaughter. Inject deep into the muscle only. Local reactions may occur at the injection sites in vaccinates, and most of these reactions resolve in 3 to 7 days following vaccination. Systemic reactions may also occur in animals following vaccination. If allergic reaction occurs, treat with epinephrine. Care should be used to avoid injecting your own fingers, hands, or other body parts. Accidental injection can cause serious local reactions. In case of human exposure, contact a physician.
ANTIBIOTIC: Gentamicin.
PRESERVATIVE: Thimerosal.
FOR ANIMAL USE ONLY
